F16.122

Clinical Causes: Recreational use of hallucinogenic drugs such as LSD, psilocybin, mescaline, or DMT Repeated exposure to hallucinogens leading to physical and psychological dependence Psychological factors, such as curiosity or peer influence, encouraging drug experimentation Underlying mental health conditions that might increase susceptibility to substance abuse Environmental triggers or stressful life events prompting drug use as a coping mechanism

Key Symptoms: Visual hallucinations, including seeing shapes, colors, or objects that aren't present Auditory hallucinations, such as hearing voices or sounds without external stimuli Altered perceptions of time, space, or self-awareness Feelings of euphoria or, conversely, anxiety and paranoia Physical symptoms like dilated pupils, increased heart rate, dizziness, or nausea Impaired judgment and difficulty concentrating Perceptual distortions that impact daily activities and social interactions

Diagnosis Path: Diagnosis typically involves a comprehensive clinical evaluation, including detailed patient history and examination. Healthcare professionals assess recent substance use, symptoms of perceptual disturbances, and any signs of intoxication. Laboratory tests, such as blood or urine screens, may be used to detect the presence of hallucinogens. Mental health assessments help determine the extent of substance abuse and any co-occurring mental health issues.

Treatment Protocols: Detoxification under medical supervision if physical dependence is present Psychological counseling, such as cognitive-behavioral therapy (CBT), to address underlying behaviors and thought patterns Support groups and peer support to foster a sense of community and accountability Medication management for co-occurring mental health issues, if applicable Educational programs about the risks and effects of hallucinogen use Development of healthy coping strategies to handle stress and triggers